Objectives Tumors of the central nervous system are dependent on expression of integrin αvβ3 for growth. As agents targeting this pathway are now in clinical trials, we evaluated receptor-mediated ...

Objectives To develop a monitoring system for targeting integrin αvβ3 in tumor angiogenesis, we evaluated the versatile carrier system with 125I-labeled cRGD peptides-gold nanoparticles for targeting ...